Public Health Trace

Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters

Drug Recall Terminated Historical recordClass II

Ricola CherryHoney Herb Throat Drops (menthol, 1.8 mg), 10 Drops per roll, Manufacturer: Ricola Ltd., 4242 Laufen, Switzerland; Distributed by: Ricola USA Inc., 6 Campus Drive, 2nd Floor South, Parsippany, NJ 07054. NDC: 54305-507-10

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Propranolol Hydrochloride Tablets, 20 mg, 100 Tablets per bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC: 69238-2078-1

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

PredniSONE Tablets, USP, 20 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801. NDC: 59746-175-06

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Nyamyc, 100,000 USP units per gram, 60 grams, Rx only, Topical Use Only, Manufactured by: Upsher-Smith Laboratories, Inc, Minneapolis, MN 55447.

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454. NDC: 45963-676-96

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Meloxicam Tablets, USP, 15 mg, 1000 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., Kurkumbh, India; Manufactured for: Cipla USA, Inc., 9100 S. Dadeland Blvd., Suite 1500 Miami, FL 33156. NDC: 69097-159-15

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-1300-01

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Lisinopril and Hydrochlorothiazide Tablets USP, 10mg/12.5mg, Rx only, 100 Tablets per bottles, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Nagpur-441 108, India. NDC: 68180-518-01

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Lillow (Levonorgestrel and Ethinyl Estradiol Tablets, USP), 0.15 mg/0.03 mg, 1 Blister Pack Containing 28 Tablets, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC 69238-1554-6

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Leader Nasal Decongestant PE (Phenylephrine HCl 10 mg), 18 Tablets per cartons, Distributed By Cardinal Health, Dublin, Ohio 43017. NDC: 70000-0126-1

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Jardiance (empagliflozin tablets), 25 mg, 30 tablets (3 blister cards with 10 tablets each), Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877. NDC: 0597-0153-37

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

HydrALAZINE Hydrochloride Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816. NDC: 23155-002-01

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

FOLIC ACID TABLETS, USP, 1MG, 100 Tablets per bottle, Rx Only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004. NDC: 69315-127-10

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Fluticasone Propionate Nasal Spray USP, 50MCG per spray, 16 g net fill weight, 120 Metered Sprays, For Intranasal Use Only, Rx Only, Manufactured for: Apotext Corp., Weston, FL 33326. NDC: 60505-0829-1

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

FIRST LANSOPRAZOLE PT 3MG/ML, 300ML, Rx Only, Distributed By: CutisPharma, Inc., Woburn, MA 01801. NDC: 65628-080-10

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

ESTRADIOL TABLETS USP, 0.5MG 100 Tablets, Tx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454. NDC: 0555-0899-02

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Enoxaparin Sodium Injection, USP, 150MG/ML Single-Dose Syringes with Automatic Safety Device, For Subcutaneous Injection, Ten 1 mL Syringes per box, Rx Only, Sandoz Inc, Princeton, NJ 08540. NDC: 0781-3299-69

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Doxycycline Capsules, USP 100 mg, 50 Capsules, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202 Unite States; Manufactured by: Lupin Limited, Nagpur - 441 108, INDIA. NDC 68180-652-08

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Donepezil HCl Tablets, 5 mg, 90 Tablets, Rx only, Distributed by: Solco Healthcare U.S. LLC, Hurracao, Puerto Rico 00791. NDC: 43547-275-09

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Donepezil HCl Tablets, 10 mg, 90 Tablets, Rx only, Distributed by: Solco Healthcare U.S. LLC, Hurracao, Puerto Rico 00791. NDC: 43547-276-09

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated: January 26, 2022
Reported by FDA: January 3, 2024
Distribution: Nationwide USA

View recall →

Data last updated: November 1, 2026 ET

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.